Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 BASF Acquires Equateq Ltd. - Nutraceuticals World

What are you searching for?

Sign in
Market Updates

BASF Acquires Equateq Ltd.

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

BASF today has acquired Equateq Ltd., a leading manufacturer of highly concentrated omega-3 fatty acids, for an undisclosed amount. With the acquisition, BASF extends its portfolio of omega-3 products for the pharmaceutical and dietary supplement industries with a new offering of highly concentrated omega-3 fatty acids.  

Equateq’s proprietary chromatographic separation methods allow flexible formulation of omega-3 fatty acids at exceptional purity levels. “Equateq’s technologies will enable us to customize fatty acid concentrates with variable ratios of EPA (eicosapentaenoic acid) and
DHA (docosahexaenoic acid) at concentration levels of up to 99% purity. This is unique in the market,” explained Martin Widmann, senior vice president, Pharma Ingredients & Services at BASF.
 
Equateq has a production site located on the Isle of Lewis in Scotland with 47 employees. Equateq with all its employees will be integrated into the Pharma Ingredients & Services unit, which is part of BASF’s Nutrition & Health division. The integration is expected to be completed by the end of 2012.
 

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters

Topics